As district judges in Pennsylvania are splitting over whether or not GlaxoSmithKline can remove cases brought over its drug Paxil to federal court, a judge in the Eastern District has transferred one of those cases to the Southern District of Texas.
U.S. District Judge Eduardo C. Robreno of the Eastern District of Pennsylvania agreed with the pharmaceutical giant that a case, one of many, filed against it belongs in Texas. The claims allege that GSK’s antidepressant drug Paxil caused birth defects in the baby born to a woman who took Paxil during her pregnancy.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
